Health
Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use
- Subjects in Herniorrhaphy Study Dosed - Successful FDA Interactions on Two Pre-clinical Pipeline Products Also Discussed SAN DIEGO, April 18, 2023 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali" or "Cali Biosciences"), a biopharmaceutical company focused on the re...
2023-04-19 11:05
1604
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses
CAMBRIDGE, Mass., April 18, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting edge technology innovation and provider of integrated solutions from "Idea to IND" (I to ITM), announced today it has entered into a collaboration agreement w...
2023-04-19 08:45
1998
AACR 2023 | ImmVira presented preclinical study results of first CAR-T enabler oncolytic product MVR-T7011 at AACR Annual Meeting
SHENZHEN, China, April 17, 2023 /PRNewswire/ -- On April 18, 2023, U.S. time,
ImmVira presented preclinical study results of CAR-T enabler oHSV product
MVR-7011 through poster publication at the American Association for Cancer
Research ("AACR") annual meeting.
2023-04-19 08:29
1725
Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting
* New preclinical data validate anti-tumor efficacy and intracranial activity of the drug candidate * Bridge submitted an IND application to the U.S. Food and Drug Administration in March, and expects to initiate the first-in-human study of BBT-207 this year SEONGNAM, South Korea and CAMBRIDG...
2023-04-19 07:00
1784
The Korea Health Industry Development Institute runs the Korean Pavilion at the 2023 HIMSS Global Health Conference and Exhibition
- Promoting the products of Korean digital healthcare companies and supporting the progress into the global market at the world's largest medical IT exhibition - CHICAGO and SEOUL, South Korea, April 18, 2023 /PRNewswire/ -- Korea Health Industry Development Institute (President Cha Soon-do, her...
2023-04-19 00:05
1702
State-owned Fund Joins Huayi Tencent's "Echartnow" Series A Financing, Kickstarting Its IPO Plan
HONG KONG, April 18, 2023 /PRNewswire/ -- Huayi Tencent Entertainment Company Limited("Huayi Tencent Entertainment", the "Company"; Stock code: 419.HK; together with its subsidiaries collectively known as the "Group") and its subsidiary "Shaanxi Yizhinuo Information Technology Company Limited" (t...
2023-04-18 23:26
2787
China Jo-Jo Drugstores Announces $7 Million Registered Direct Offering
HANGZHOU, China, April 18, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...
2023-04-18 21:21
2335
Chamlion completed 236 million yuan in Series B fundraising, building a new eco-system of digital dentistry
NANJING, China, April 18, 2023 /PRNewswire/ -- Recently, Chamlion, which focuses on the digitalization of the full process of dentistry, announced that it has completed the B round fundraising of236 million yuan. This round of fundraising was led by 3H Health, followed by Vertex Ventures China, e...
2023-04-18 21:10
2077
Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial
CHENGDU, China, April 18, 2023 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report that the Company has begun dosing patients in its Androgenetic Alopecia (AGA) Phase 2 clinical trial (NCT05802173) of topical TDM-105795 sol...
2023-04-18 21:00
1489
South Korean Biotech, ToolGen Leads the Development of Numerous Cutting-Edge Genome Editing Techniques
SEOUL, South Korea, April 18, 2023 /PRNewswire/ -- Until now, most of the major
breakthroughs in the CRISPR field have been led by US academics. Not anymore;
Toolgen, aSouth Korea-based biotech company, has reported three breakthrough
techniques in top-tier scientific journals.
2023-04-18 21:00
1648
GC Genome to Present the Brand New Liquid Biopsy Platform for Cancer Detection at AACR Annual Meeting 2023
YONGIN, South Korea, April 18, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that the company will present data showcasing the deep learning algorithm that detects and classifies multi-cancer using methylation information and genomic data at the Americ...
2023-04-18 13:36
1565
NOVOSENSE NST1002 facilitates accurate CGM measurement with glucose monitoring black technology
SHANGHAI, April 17, 2023 /PRNewswire/ -- Glucose monitoring is a key link in diabetes management. Currently, there are two main methods for self-monitoring of glucose in patients with diabetes, one is the traditional blood glucose Monitoring (BGM), and the other is continuous glucose monitoring (...
2023-04-18 09:28
1730
AACR 2023 | Ascentage Pharma Presents Results from Three Studies Underscoring Exploratory Efforts in Potential New Indications
SUZHOU, China and ROCKVILLE, Md., April 17, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it had released results from three preclinic...
2023-04-18 09:08
1689
GC Biopharma celebrates 'World Hemophilia Day'
* To display a large media façade on its Yong-in R&D Center YONGIN, South Korea, April 17, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, takes part in a campaign to celebrate World Hemophilia Day. The company announced that a l...
2023-04-18 09:03
1645
USANA Malaysia Donates MYR 40,000 to Local Flood Relief
Donation in partnership with Suriana Welfare Society Malaysia KUALA LUMPUR, Malaysia, April 18, 2023 /PRNewswire/ -- Heavy flooding in Johor has led USANA Malaysia to donateMYR 40,000 in relief funds for those affected by this natural disaster. Beyond this donation, the company and its Associates...
2023-04-18 08:24
1999
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-18 08:00
2189
Promising Efficacy of AT101 CAR-T for Blood Cancer
SEOUL, South Korea, April 17, 2023 /PRNewswire/ -- AbClon, a South Korean biotech firm, presented non-clinical and phase 1 interim results of its AT101 novel CAR-T therapy at the annual 2023 AACR conference. AT101 targets the CD19 protein for treatment of blood cancer. AT101 demonstrated superio...
2023-04-18 02:00
1670
Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2022
BEIJING, April 17, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it filed its annual report on Form 20-F for the fiscal year ende...
2023-04-17 20:24
2456
Orion Health launches Orchestral - a once in a generation giant leap forward for health data
Orchestral reimagines the aggregation of data and how it is used in healthcare in the modern machine learning era. AUCKLAND, New Zealand, April 17, 2023 /PRNewswire/ -- The Orchestral health intelligence platform, announced at HIMSS23, is the biggest step forward in health data since the advent ...
2023-04-17 20:00
1766
Asieris Releases 2022 Annual Report: Makes Steady Progress in its Clinical Development, Global Expansion to Treat Genitourinary Tumors, and Implementing its Commercialization Strategy to Provide Integrated Diagnosis-to-Treatment Solutions
SHANGHAI, April 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in the discovery, development and commercialization of innovative drugs that treat genitourinary (GU) tumors and other related diseases, today released its 2022 annual report. Whil...
2023-04-17 18:30
1933
Week's Top Stories
Most Reposted
Mastercard goes OTP-free in APAC for faster, safer online transactions
[Picked up by 326 media titles]
2024-11-06 09:00Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 309 media titles]
2024-11-12 09:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 285 media titles]
2024-11-12 11:00
Most Read
Mastercard goes OTP-free in APAC for faster, safer online transactions
2024-11-06 09:00
13200
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10120
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7470
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6188
